ORG Partners LLC Makes New Investment in Revvity, Inc. (NYSE:RVTY)

ORG Partners LLC purchased a new stake in shares of Revvity, Inc. (NYSE:RVTY) during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 290 shares of the company’s stock, valued at approximately $32,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. State of Michigan Retirement System acquired a new stake in Revvity in the fourth quarter valued at $3,688,000. Gulf International Bank UK Ltd acquired a new stake in shares of Revvity in the fourth quarter valued at about $1,136,000. State of Alaska Department of Revenue bought a new position in shares of Revvity during the fourth quarter worth about $1,456,000. Exchange Traded Concepts LLC acquired a new position in shares of Revvity in the fourth quarter worth approximately $1,303,000. Finally, KBC Group NV bought a new stake in Revvity in the third quarter valued at approximately $25,301,000. 86.65% of the stock is currently owned by institutional investors.

Revvity Trading Down 2.0 %

Shares of Revvity stock opened at $100.30 on Wednesday. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.77 and a current ratio of 2.07. Revvity, Inc. has a 52 week low of $79.50 and a 52 week high of $137.09. The stock has a 50 day moving average price of $104.96 and a two-hundred day moving average price of $101.71. The stock has a market capitalization of $12.39 billion, a PE ratio of 18.24, a price-to-earnings-growth ratio of 2.69 and a beta of 1.09.

Revvity (NYSE:RVTY) last posted its quarterly earnings results on Thursday, February 1st. The company reported $1.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.15 by $0.10. Revvity had a net margin of 25.20% and a return on equity of 7.41%. The business had revenue of $695.90 million during the quarter. As a group, equities analysts anticipate that Revvity, Inc. will post 4.65 earnings per share for the current fiscal year.

Revvity Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 10th. Investors of record on Friday, April 19th will be issued a $0.07 dividend. The ex-dividend date is Thursday, April 18th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.28%. Revvity’s dividend payout ratio is presently 5.09%.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on the stock. Wells Fargo & Company assumed coverage on shares of Revvity in a research report on Tuesday, December 19th. They issued an “equal weight” rating and a $95.00 price target on the stock. UBS Group cut shares of Revvity from a “buy” rating to a “neutral” rating and upped their price target for the company from $105.00 to $125.00 in a research report on Tuesday, January 16th. KeyCorp lifted their price objective on Revvity from $110.00 to $126.00 and gave the stock an “overweight” rating in a research report on Friday, February 2nd. Evercore ISI upgraded Revvity from an “in-line” rating to an “outperform” rating and upped their target price for the company from $88.00 to $125.00 in a research report on Thursday, January 4th. Finally, Raymond James raised their target price on Revvity from $106.00 to $127.00 and gave the stock an “outperform” rating in a research note on Friday, February 2nd. Six research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $118.91.

Insider Activity at Revvity

In other Revvity news, insider Prahlad R. Singh sold 21,217 shares of the business’s stock in a transaction that occurred on Monday, February 5th. The stock was sold at an average price of $104.28, for a total transaction of $2,212,508.76. Following the completion of the sale, the insider now directly owns 92,801 shares of the company’s stock, valued at approximately $9,677,288.28. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.60% of the stock is owned by insiders.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.